About BiomaRx Therapeutics
BiomaRx Therapeutics is a Healthcare company based in Cambridge (United States) founded in 2014. Diagnostic and therapeutic tools for pancreatic cancer are developed. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Similar companies include Guardant Health, GRAIL and Delfi Diagnostics; 3 of its 3 listed similar companies have raised funding.
Company details
BiomaRx Therapeutics was founded in 2014 in Cambridge, United States, within the biotechnology sector. A panel of biomarkers is developed by the company using genomics, epigenomics, proteomics, bioinformatics, and systems biology. These tools support risk assessment for malignant pancreatic ductal adenocarcinoma precursor lesions, enable early detection in high-risk individuals, and identify therapeutic drug targets for pancreatic cancer treatment.
- Headquarters Cambridge, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biomarx.com
Similar companies to BiomaRx Therapeutics
BiomaRx Therapeutics has 3 listed similar companies in our database, 3 of them funded. They include Guardant Health, GRAIL and Delfi Diagnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| delfidiagnostics.com | 2019 | Baltimore, United States | $331.59M | Provider of DNA sequencing for cancer detection |
Detailed similar companies of BiomaRx Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as BiomaRx Therapeutics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BiomaRx Therapeutics
BiomaRx Therapeutics was founded in 2014.
BiomaRx Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
BiomaRx Therapeutics was founded in 2014 in Cambridge, United States, within the biotechnology sector. A panel of biomarkers is developed by the company using genomics, epigenomics, proteomics, bioinformatics, and systems biology. These tools support risk assessment for malignant pancreatic ductal adenocarcinoma precursor lesions, enable early detection in high-risk individuals, and identify therapeutic drug targets for pancreatic cancer treatment.
BiomaRx Therapeutics's top competitors include Guardant Health, GRAIL and Delfi Diagnostics.